Liver injury induced by the Japanese herbal drug Kamishoyosan

Gastroenterology and Hepatology

Volumn 7, Issue 10, 2011, Pages 692-695

  Inoue, Hiromu ^a   Yamazaki, Sho ^b   Shimizu, Maki ^a   Uozaki, Hiroshi ^a   Goto, Tadashi ^a   Ohnishi, Shin ^a   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCYRRHIZIC ACID; HERBACEOUS AGENT; KAMISHOYOSAN; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BED REST; BILIRUBIN BLOOD LEVEL; CASE REPORT; DRUG WITHDRAWAL; FATIGUE; FEMALE; HOT FLUSH; HUMAN; LIVER BIOPSY; LIVER NECROSIS; LYMPHOCYTIC INFILTRATION; MENOPAUSAL SYNDROME; NIGHT SWEAT; PLASMA CELL; PORTAL VEIN; TOXIC HEPATITIS;

EID: 81155128350     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Yasui T, Matsui S, Yamamoto S, et al. Effects of Japanese traditional medicines on circulating cytokine levels in women with hot flashes. Menopause. 2011;18:85-92.
2. Toriizuka K, Kamiki H, Ohmura N, et al. Anxiolytic effect of Gardentae Fructus-extract containing active ingredient from Kamishoyosan, a Japanese traditional Kampo medicine. Life Sci. 2005;77:3010-3020. (Pubitemid 41423738)
3. Mantani N, Hisanaga A, Korure T, et al. Four cases of panic disorder successfully treated with Kampo (Japanese herbal) medicines: Kamishoyosan and Hangekoboku-to. Psychiatry Clin Neurosci. 2002;56:617-620. (Pubitemid 35364595)
4. Yamada K, Kanba S. Effectiveness of kamishoyosan for premenstrual dysphoric disorder open-labeled pilot study. Psychiatry Clin Neurosci. 2007;61:323-325. (Pubitemid 46683987)
5. Lee JG, Shin BS, Lee YC, et al. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia with schizophrenia: a 16-week open trial. Psychiatry Clin Neurosci. 2007;61:509-514. (Pubitemid 47414852)
6. Melchart D, Linde K, Hager S, et al. Liver enzyme elevations in patients treated with traditional Chinese medicine. JAMA. 1999;282:28-29. (Pubitemid 29318925)
7. Nakazawa Y, Suzuki S, Negishi E, et al. Investigation of changes in ALT levels after administration of kampo medicines at Akiba Hospital. Jpn J Pharm Health Care Sci. 2006;32:504-510.
8. Terada M, Kitazawa H, Kawakami J, et al. Pharmacoepidemiology of interstitial pneumonia and liver dysfunction associated with kampo medicine. Jpn J Pharm Health Care Sci. 2002;28:425-434.
9. Willett KL, Roth RA, Walker L. Workshop overview: hepatotoxicity assessment for botanical dietary and supplements. Toxicol Sci. 2004;79:4-9. (Pubitemid 38660241)
10. De Berardinis V, Moulis C, Maurice M, et al. Human microsomal epoxide hydrolase is the target of germander induced autoantibodies on the surface of human hepatocytes. Mol Pharmacol 2000;58:542-551.
11. Miyake Y, Iwasaki Y, Kobashi H, et al. Clinical features of antinuclear antibodies-negative type 1 autoimmune hepatitis. Hepatol Res. 2009;39:241-246.
12. Fujiwara K, Fukuda Y, Yokosuka O. Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis. J Gastroenterol. 2008;43:951-958.